Ignite Creation Date:
2024-05-06 @ 10:20 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03228667
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-29
First Post:
2017-07-21
Brief Title:
QUILT-3055 A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
Sponsor:
ImmunityBio Inc
Organization:
ImmunityBio Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Colorectal Cancer |
| Non-Small Cell Lung Cancer |
| Small Cell Lung Cancer |
| Urothelial Carcinoma |
| Head and Neck Squamous Cell Carcinoma |
| Merkel Cell Carcinoma |
| Melanoma |
| Renal Cell Carcinoma |
| Gastric Cancer |
| Cervical Cancer |
| Hepatocellular Carcinoma |
| Microsatellite Instability |
| Mismatch Repair Deficiency |
Keywords:
| Name | View |
|---|---|
| Tecentriq | View |
| Pembrolizumab | View |
| Nivolumab | View |
| Non-Small Cell Lung Cancer NSCLC | View |
| Immunotherapy | View |
| Interleukin-15 | View |
| PD-1 Checkpoint Inhibitor | View |
| ALT-803 | View |
| Atezolizumab | View |
| Avelumab | View |
| Small Cell Lung Cancer SCLC | View |
| Urothelial Carcinoma | View |
| Head and Neck Squamous Cell Carcinoma HNSCC | View |
| Merkel Cell Carcinoma MCC | View |
| Melanoma | View |
| Renal Cell Carcinoma RCC | View |
| Gastric Cancer | View |
| Cervical Cancer | View |
| Hepatocellular Carcinoma HCC | View |
| Microsatellite Instability-High MSI-H | View |
| PD-L1 Checkpoint Inhibitor | View |
| Mismatch Repair Deficient dMMR Solid Tumor Cancer | View |
| Colorectal Cancer CRC | View |
| Durvalumab | View |
| PD-L1 t-haNK | View |
| N-803 | View |
| Keytruda | View |
| Opdivo | View |
| Imfinzi | View |
| Bavencio | View |